Stockscreener 앱 받기
122.46
0.13%
-0.21
전일 마감가:
$122.25
열려 있는:
$120.56
하루 거래량:
210.83K
Relative Volume:
0.19
시가총액:
$13.23B
수익:
$769.10M
순이익/손실:
$46.67M
주가수익비율:
349.89
EPS:
0.35
순현금흐름:
$119.79M
1주 성능:
+4.20%
1개월 성능:
+28.04%
6개월 성능:
+234.69%
1년 성능:
+73.60%
1일 변동 폭
$119.17
$122.42
1주일 범위
$116.31
$123.44
52주 변동 폭
$28.66
$123.44
코르셉트 테라퓨틱스 Stock (CORT) Company Profile
명칭
Corcept Therapeutics Inc
전화
650.688.8803
주소
101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Compare CORT vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CORT
Corcept Therapeutics Inc
|
122.42 | 13.09B | 769.10M | 46.67M | 119.79M | 0.35 |
VRTX
Vertex Pharmaceuticals Inc
|
550.55 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
829.69 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,014.42 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
138.50 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.22 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
코르셉트 테라퓨틱스 Stock (CORT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-05-13 | 업그레이드 | UBS | Neutral → Buy |
| 2026-03-26 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2025-12-31 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2025-12-16 | 개시 | UBS | Neutral |
| 2025-11-18 | 개시 | Wolfe Research | Peer Perform |
| 2023-11-06 | 업그레이드 | Truist | Hold → Buy |
| 2023-04-11 | 개시 | SVB Securities | Market Perform |
| 2023-04-04 | 개시 | Piper Sandler | Overweight |
| 2023-02-15 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-08-01 | 다운그레이드 | Truist | Buy → Hold |
| 2022-07-27 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-06-27 | 재개 | Canaccord Genuity | Buy |
| 2022-02-02 | 개시 | Canaccord Genuity | Buy |
| 2022-01-28 | 개시 | Truist | Buy |
| 2020-08-05 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-09-24 | 개시 | Jefferies | Buy |
| 2019-09-06 | 개시 | H.C. Wainwright | Buy |
| 2019-02-04 | 다운그레이드 | B. Riley FBR | Buy → Neutral |
| 2018-08-10 | 재확인 | Stifel | Hold |
| 2018-05-31 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-03-09 | 개시 | B. Riley FBR, Inc. | Buy |
| 2017-08-31 | 개시 | Stifel | Buy |
| 2017-02-02 | 개시 | Ladenburg Thalmann | Buy |
| 2015-04-21 | 개시 | FBR Capital | Outperform |
| 2014-01-13 | 다운그레이드 | Stifel | Buy → Hold |
| 2013-08-09 | 다운그레이드 | Janney | Buy → Neutral |
| 2013-08-09 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2012-02-21 | 재확인 | JMP Securities | Mkt Outperform |
| 2010-01-06 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2008-07-17 | 개시 | Rodman & Renshaw | Mkt Outperform |
| 2007-06-21 | 업그레이드 | Punk, Ziegel & Co | Mkt Perform → Accumulate |
모두보기
코르셉트 테라퓨틱스 주식(CORT)의 최신 뉴스
Corcept Therapeutics stock hits all-time high at 122.5 USD By Investing.com - Investing.com Canada
Corcept Therapeutics(CORT.US) Director Sells US$12.25 Million in Common Stock - Moomoo
Reflecting On Branded Pharmaceuticals Stocks’ Q2 Earnings: Corcept (NASDAQ:CORT) - Yahoo Finance
Zacks Research Has Bullish Forecast for CORT Q3 Earnings - MarketBeat
CORT Stock Slips After-Hours On Weak Q4 Print: Retail Is Watching April FDA Meeting For Relacorilant As Next Catalyst - Stocktwits
Truist Financial Initiates Corcept Therapeutics(CORT.US) With Buy Rating, Announces Target Price $164 - Moomoo
Corcept Therapeutics (NASDAQ:CORT) Director James Wilson Sells 10,000 Shares of Stock - MarketBeat
Corcept (NASDAQ: CORT) exec sells 10,000 shares at $116 - Stock Titan
Corcept (NASDAQ: CORT) director sells 10,000 shares under 10b5-1 plan - Stock Titan
Corcept (NASDAQ: CORT) director plans open-market sale of 103,606 shares - Stock Titan
Truist Adjusts Price Target on Corcept Therapeutics to $164 From $50, Maintains Buy Rating - marketscreener.com
Truist assumes Corcept Therapeutics stock with buy rating on Cushing’s opportunity - Investing.com Nigeria
CORCEPT THERAPEUTICS INC SEC Filing (Aug 17, 2026) - Stock Titan
CORT Looks 65.7% Overvalued on GF Value™ - GuruFocus
Corcept, Revolution Medicines lead ten large-cap healthcare stocks surging in 2026 (XLV:NYSEARCA) - Seeking Alpha
23,257 Shares in Corcept Therapeutics Incorporated $CORT Purchased by GSA Capital Partners LLP - MarketBeat
Corcept therapeutics chief development officer sells $1.8m in stock - Investing.com
Corcept therapeutics chief development officer sells $1.8m in stock By Investing.com - Investing.com Canada
Corcept Therapeutics (CORT) CBO reports 17,530-share stock gifts and trust holdings - Stock Titan
Renaissance Technologies (CORT) discloses 4.90% beneficial stake in Corcept Therapeutics - Stock Titan
Corcept Therapeutics Incorporat (CORT) Stock Forecasts - Yahoo Finance
Sean Maduck Sells 1,031 Shares of Corcept Therapeutics (NASDAQ:CORT) Stock - MarketBeat
William Guyer Sells 16,300 Shares of Corcept Therapeutics (NASDAQ:CORT) Stock - MarketBeat
Corcept chief development officer sells $418,561 of stock By Investing.com - Investing.com Nigeria
Corcept chief development officer sells $418,561 of stock - Investing.com
Sei Investments Co. Sells 62,377 Shares of Corcept Therapeutics Incorporated $CORT - marketbeat.com
Amundi Acquires New Shares in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept Therapeutics (CORT) Litigation: Hagens Berman Alerts Corcept (CORT) Investors to Securities Class Action and April 21 Lead Plaintiff Deadline (PR Newswire) - Aktiellt
California State Teachers Retirement System Boosts Stake in Corcept Therapeutics Incorporated $CORT - marketbeat.com
12,478 Shares in Corcept Therapeutics Incorporated $CORT Purchased by Evanson Financial LLC - MarketBeat
Corcept Therapeutics Incorporat (CORT) Stock forecasts - Yahoo Finance UK
Corcept Therapeutics (CORT) Stock May Trade At A Discount Yet A Premium On Sales - Yahoo Finance
Corcept CDO William Guyer sells $418,561 in common stock By Investing.com - Investing.com South Africa
Corcept CDO William Guyer sells $418,561 in common stock - Investing.com
Insider Selling: Corcept Therapeutics (NASDAQ:CORT) Insider Sells 3,700 Shares - MarketBeat
Janus Henderson Group PLC Acquires 10,817 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept Therapeutics (NASDAQ:CORT) Insider Sells 20,305 Shares of Stock - MarketBeat
Corcept Therapeutics (NASDAQ:CORT) Insider Joseph Douglas Lyon Sells 1,540 Shares of Stock - MarketBeat
Corcept Therapeutics Stock Shines at New All-Time Highs Despite Its Valuation - Yahoo Finance
Corcept Therapeutics' (NASDAQ:CORT) Anemic Earnings Might Be Worse Than You Think - Moomoo
Parallel Advisors LLC Buys 96,763 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
CORT (NASDAQ: CORT) insider schedules 20,000-share option-related sale - Stock Titan
John Hussman's Top Q2 2026 Move: Exiting Corcept Therapeutics In - GuruFocus
Insider Selling: Corcept Therapeutics (NASDAQ:CORT) CFO Sells $9,176,800.00 in Stock - MarketBeat
Corcept Therapeutics (CORT) CFO exercises options and sells 80,000 shares - Stock Titan
CORCEPT THERAPEUTICS INC SEC Filing (Aug 3, 2026) - Stock Titan
FAS Wealth Partners Inc. Grows Stock Position in Corcept Therapeutics Incorporated $CORT - MarketBeat
Perceptive Advisors LLC Takes Position in Corcept Therapeutics Incorporated $CORT - marketbeat.com
Corcept Therapeutics (NASDAQ:CORT) Upgraded at Wall Street Zen - MarketBeat
Corcept: Commercial Evidence™ with Agentic Call Report - Veeva
Corcept Therapeutics (CORT) Stock Soars 22% After Hours: Here's What You Need To Know - webull.com
코르셉트 테라퓨틱스 (CORT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.14%
0.28%
자본화:
|
볼륨(24시간):